Non-Surgical Rhinoplasty in Singapore

The nose is the highest-risk site on the face for injectable treatment. It is also where small, well-placed volumes produce disproportionate improvement.

1. Non-surgical treatment adds; it cannot reduce

A dorsal hump can be camouflaged by building the radix and supratip around it. The hump itself is not removed. Patients wanting a smaller nose need surgery; patients wanting a straighter profile often do not.

2. Vascular risk here is real and well documented

The nasal dorsum has limited collateral circulation. Intravascular injection can cause skin necrosis and, rarely, visual loss. This is why technique, volume discipline and immediate hyaluronidase availability are non-negotiable.

3. Threads and filler solve different problems

Polydioxanone threads add definition along a line and recruit collagen. Filler adds projection at a point. A tip that needs lifting and a bridge that needs height are not the same request.

4. Previous rhinoplasty changes the risk calculus

Scarred, surgically altered tissue has unpredictable vascular anatomy. Injectable treatment after surgery warrants greater caution, not less.

Common questions